Contact
Please use this form to send email to PR contact of this press release:
Biomed Industries, Inc. to Present Combination Therapy Phase 2 Protocol of NA-931 and Tirzepatide at ICOCD-2025
TO:
Dr. Lloyd L. Tran
Biomed Industries, Inc.
+1 800-824-5135